2024 must be the occasion for the international community to seriously discuss how to align drug policies with health, human rights and sustainable development.
Presenting personal testimony as well as data, the report concludes there is little evidence that policies aimed at the prohibition and eradication of drugs have been effective or positive.
The WHO undertook to ensure that the review would not be delayed and Bolivia's Vice-resident stressed the importance of a comprehensive process, including due attention to traditional uses.
Jamaica's cannabis regulation must shift course and priorities: from enabling corporate greed and perpetuating racial inequality, to prioritising social equity and reparations.
High Commissioner Volker Türk encouraged more countries to begin their journey toward understanding drug use as a public health and human rights issue, including through the adoption of decriminalisation.
As the presence of nitazenes, powerful synthetic opioids, increase in the UK drug supply, the 'Stayin' Alive' campaign strongly advises people who use heroin, oxycodone, and benzodiazepines to adopt additional safety measures, including testing, reducing dosage, and carrying naloxone.
Prevention and criminalisation of the distribution of safer smoking kits leave stimulant users to devise their own creative solutions, which can lead to entirely avoidable health problems.
A further four associations are in the process of attaining operational licenses to provide cannabis to their members while seeking to avoid commercialisation.
Aidsfonds and the Robert Carr Fund explore how we can empower communities to lead change in HIV, health and rights by discussing methods, challenges, and opportunities in shifting power towards community-led approaches.
